Author:
Kawamura Koji,Hayakawa Jin,Akahoshi Yu,Harada Naonori,Nakano Hirofumi,Kameda Kazuaki,Ugai Tomotaka,Wada Hidenori,Yamasaki Ryoko,Ishihara Yuko,Sakamoto Kana,Ashizawa Masahiro,Sato Miki,Terasako-Saito Kiriko,Kimura Shun-ichi,Kikuchi Misato,Nakasone Hideki,Yamazaki Rie,Kanda Junya,Kako Shinichi,Tanihara Aki,Nishida Junji,Kanda Yoshinobu
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Kawamura K, Wada H, Yamasaki R, Ishihara Y, Sakamoto K, Ashizawa M, et al. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15:457–65.
2. Schuchter LM, Wingard JR, Piantadosi S, Burns WH, Santos GW, Saral R. Herpes zoster infection after autologous bone marrow transplantation. Blood. 1989;74:1424–7.
3. Offidani M, Corvatta L, Olivieri A, Mele A, Brunori M, Montanari M, et al. A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation. Clin Infect Dis. 2001;32:1414–22.
4. Rogers JE, Cumpston A, Newton M, Craig M. Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population. Transpl Infect Dis. 2011;13:480–4.
5. Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, et al. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrow Transplant. 2009;15:724–9.